{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:07:04Z","timestamp":1792728424331,"version":"4.5.0"},"reference-count":48,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Dyslipidemia is one of the most important modifiable risk factors in the pathogenesis of cardiovascular disease in the general population, but its importance in the hemodialysis (HD) population is uncertain. Materials and Methods: This retrospective cohort study includes HD patients hospitalized due to acute coronary syndrome (ACS) in the period 2015\u20132020 with lipid profile data during ACS. A control group with preserved kidney function was matched. Risk factors for 30-day and 1-year mortality were assessed. Results: Among 349 patients included in the analysis, 246 were HD-dependent (\u201cHD group\u201d). HD group patients had higher prevalence of diabetes, hypertension, and heart disease than the control group. At ACS hospitalization, lipid profile and chronic statin treatment were comparable between groups. Odds ratios for 30-day mortality in HD vs. control group was 5.2 (95% CI 1.8\u201315; p = 0.002) and for 1-year, 3.4 (95% CI 1.9\u20136.1; p &lt;0.001). LDL and LDL &lt; 70 did not change 30-day and 1-year mortality rates in the HD group (p = 0.995, 0.823, respectively). However, survival after ACS in HD patients correlated positively with nutritional parameters such as serum albumin (r = 0.368, p &lt; 0.001) and total cholesterol (r = 0.185, p &lt; 0.001), and inversely with the inflammatory markers C-reactive protein (CRP; r = \u22120.348, p &lt; 0.001) and neutrophils-to-lymphocytes ratio (NLR; r = \u22120.181, p = 0.019). Multivariate analysis demonstrated that heart failure was the only significant predictor of 1-year mortality (OR 2.8, p = 0.002). LDL &lt; 70 mg\/dL at ACS hospitalization did not predict 1-year mortality in the HD group. Conclusions: Despite comparable lipid profiles and statin treatment before and after ACS hospitalization, mortality rates were significantly higher among HD group. While malnutrition\u2013inflammation markers were associated with survival of dialysis patients after ACS, LDL cholesterol was not. Thus, our study results emphasize that better nutritional status and less inflammation are associated with improved survival among HD patients.<\/jats:p>","DOI":"10.3390\/medicina59071312","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:35:04Z","timestamp":1689554104000},"page":"1312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Clinical Significance of LDL-Cholesterol on the Outcomes of Hemodialysis Patients with Acute Coronary Syndrome"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1894-6956","authenticated-orcid":false,"given":"Keren","family":"Cohen-Hagai","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba 44281, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Benchetrit","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba 44281, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Wand","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon 7830604, Israel"},{"name":"Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Grupper","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"},{"name":"Department of Nephrology and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Shashar","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Laniado Hospital, Netanya 4244916, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Solo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pain and Intensive Care, Meir Medical Center, Kfar Saba 4428164, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pereg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Meir Medical Center, Kfar Saba 4428164, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Zitman-Gal","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba 44281, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Haskiah","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"},{"name":"Department of Internal Medicine D, Meir Medical Center, Kfar Saba 4428164, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Erez","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel"},{"name":"Department of Internal Medicine D, Meir Medical Center, Kfar Saba 4428164, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17788","DOI":"10.1038\/s41598-022-22474-9","article-title":"Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease","volume":"12","author":"Yoskovitz","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"US Renal Data System (1999). USRDS 1999 annual data report. Am. J. Kidney Dis., 34, S87\u2013S94.","DOI":"10.1016\/S0272-6386(99)80018-3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000508836","article-title":"Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis","volume":"51","author":"Topaz","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11255-019-02218-x","article-title":"Clinical outcomes of stroke in hemodialysis patients: A retrospective single-center study","volume":"51","author":"Nacasch","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"Guideline on the management of blood cholesterol: Executive summary: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1097\/01.ASN.0000081698.10331.83","article-title":"Impact of dyslipidemia in end-stage renal disease","volume":"14","author":"Prichard","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0272-6386(12)70294-9","article-title":"The uremic dyslipidemia: A cross-sectional and longitudinal study","volume":"20","author":"Avram","year":"1992","journal-title":"Am. J. Kidney Dis."},{"key":"ref_9","first-page":"331","article-title":"Dyslipidemia in patients with renal disease","volume":"17","author":"Elisof","year":"1996","journal-title":"J. Drug Dev. Clin. Pr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated with hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists (CTT) Collaboration (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomized trials. Lancet, 376, 1670\u20131681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists (CTT) Collaboration (2005). Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet, 366, 1267\u20131278.","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1523-1755.2002.00324.x","article-title":"Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients","volume":"61","author":"Iseki","year":"2002","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","article-title":"HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients","volume":"61","author":"Seliger","year":"2002","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2004.09.025","article-title":"HMGCoA reductase inhibitor use is associated with mortality reduction in hemodialysis patients","volume":"45","author":"Mason","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1681\/ASN.V961018","article-title":"Myocyte\/capillary mismatch in the heart of uremic patients","volume":"9","author":"Amann","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1159\/000510771","article-title":"Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality","volume":"51","author":"Einbinder","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1159\/000518399","article-title":"The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients","volume":"52","author":"Erez","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Choi, S.R., Lee, Y.K., Cho, A.J., Park, H.C., Han, C.H., Choi, M.J., Koo, J.R., Yoon, J.W., and Noh, J.W. (2019). Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216415"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1523-1755.2001.00804.x","article-title":"Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialys patients","volume":"60","author":"Kaysen","year":"2001","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000083529","article-title":"Low-density lipoprotein cholesterol: Association with mortality and hospitalization in hemodialysis patients","volume":"23","author":"Chiang","year":"2005","journal-title":"Blood Purif."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.291.4.451","article-title":"Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11255-019-02166-6","article-title":"The relationship of blood lymphocute-to-neutrophil ratio with nutritional markers and health outcomes in hemodialysis patients","volume":"51","author":"Campa","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): A randomized placebo-controlled trial","volume":"377","author":"Baignet","year":"2011","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Jardine","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000032033.39301.6A","article-title":"Statin therapy in acute coronary syndromes, mechanistic insight into clinical benefit","volume":"22","author":"Sposito","year":"2002","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_28","first-page":"604","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)","volume":"5","author":"Levey","year":"2009","journal-title":"New Equ. Estim. Glomerular Filtr. Rate. Ann. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizations","volume":"351","author":"Go","year":"2004","journal-title":"N. Eng. J. Med."},{"key":"ref_31","first-page":"1573","article-title":"Statins, inflammation and kidney disease","volume":"6","author":"Krane","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000337821","article-title":"Lipid disorders in uremia and dialysis","volume":"178","author":"Bakris","year":"2012","journal-title":"Contrib. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: Effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) multicenter randomized placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","author":"Tonelli","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jjcc.2014.03.016","article-title":"Associations beween lipid profile and MACE in hemodialysis patients with percutaneous coronary intervention: From the FU-Registry","volume":"65","author":"Nagata","year":"2015","journal-title":"J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2019.05.002","article-title":"Statin therapy among chronic kidney disease patients presenting with acute coronary syndrome","volume":"286","author":"Natanzon","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/ajkd.1998.v32.pm9669431","article-title":"Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients","volume":"32","author":"Bologa","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/oxfordjournals.aje.a116977","article-title":"Changes in serum cholesterol level and mortality: A 30-year followup. The finish cohorts of the sevne countries study","volume":"139","author":"Pekkanen","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.ajkd.2009.06.029","article-title":"Association of LDL cholesterol and inflammation with cardiovascular events and mortality in patients with type 2 diabetes mellitus","volume":"54","author":"Krane","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_11.28","article-title":"The malnutrition, inflammation, and atherosclerosis (MIA) syndrome","volume":"17","author":"Lindholm","year":"2002","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/0886022X.2012.734429","article-title":"Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease","volume":"35","author":"Okyay","year":"2013","journal-title":"Ren. Fail."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/0886022X.2011.641514","article-title":"The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients","volume":"34","author":"Turkmen","year":"2012","journal-title":"Ren. Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000437005","article-title":"Relationship of neutrophil-to-lymphocyte ratio and serum albumin levels with C-reactive protein in hemodialysis patients: Results from two international cohort studies","volume":"130","author":"Malhotra","year":"2015","journal-title":"Nephron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9327136","DOI":"10.1155\/2017\/9327136","article-title":"High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients","volume":"2017","author":"Li","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5835\/jecm.omu.30.02.008","article-title":"Neutrophil to lymphocyte ratio in predicting short-term mortality in hemodialysis patients","volume":"30","author":"Erdem","year":"2013","journal-title":"J. Exp. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Kushner","year":"2013","journal-title":"Circulation"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:12:34Z","timestamp":1760127154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["medicina59071312"],"URL":"https:\/\/doi.org\/10.3390\/medicina59071312","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]}}}